STOCK TITAN

Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ironwood Pharmaceuticals (NASDAQ: IRWD) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 5:20 p.m. ET. The presentation will include a corporate overview and a Q&A session. Interested parties can access a live webcast via Ironwood's website, with a replay available for 14 days post-conference. Ironwood specializes in developing treatments for gastrointestinal diseases, notably linaclotide for IBS-C and CIC, and was founded in 1998, based in Boston.

Positive
  • None.
Negative
  • None.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, will provide a corporate overview during a presentation and Q&A session at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:20 p.m. Eastern Time.

A live webcast of Ironwood’s presentation will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.

FAQ

When will Ironwood Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Ironwood Pharmaceuticals will present on January 11, 2021, at 5:20 p.m. Eastern Time.

Where can I watch the Ironwood Pharmaceuticals presentation?

You can watch the presentation live on Ironwood's website in the Investors section.

Is there a replay of the Ironwood Pharmaceuticals conference presentation?

Yes, a replay of the webcast will be available for 14 days following the conference.

What is Ironwood Pharmaceuticals known for?

Ironwood Pharmaceuticals is known for developing linaclotide, a leading treatment for IBS-C and CIC.

Where is Ironwood Pharmaceuticals headquartered?

Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

Ironwood Pharmaceuticals, Inc. -

NASDAQ:IRWD

IRWD Rankings

IRWD Latest News

IRWD Stock Data

554.76M
157.19M
1.68%
105.53%
6.85%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BOSTON